Hershey Trust CO Guardant Health, Inc. Transaction History

Hershey Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$80.32 - $111.8 $1.53 Million - $2.13 Million	-19,048 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$60.49 - $97.5 $1.73 Million - $2.79 Million	-28,574 Reduced 60.0%	19,048 $1.55 Million
Q1 2020 Apr 20, 2020	BUY	$59.04 - $88.81 $843,563 - $1.27 Million	14,288 Added 42.86%	47,622 $3.31 Million
Q4 2019 Jan 28, 2020	SELL	$59.49 - $82.78 $283,291 - $394,198	-4,762 Reduced 12.5%	33,334 $2.61 Million
Q3 2019 Oct 31, 2019	BUY	$62.59 - $110.3 $2.38 Million - $4.2 Million	38,096 New	38,096 $2.43 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.